These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 8973741)
1. New antifungal therapy for children. Suarez S Adv Dermatol; 1997; 12():195-208; discussion 209. PubMed ID: 8973741 [No Abstract] [Full Text] [Related]
2. The use of systemic antimycotics in dermatotherapy. Niewerth M; Korting HC Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319 [TBL] [Abstract][Full Text] [Related]
3. Onychocryptosis as consequence of effective treatment of dermatophytic onychomycosis. Bonifaz A; Paredes V; Fierro L J Eur Acad Dermatol Venereol; 2007 May; 21(5):699-700. PubMed ID: 17447997 [No Abstract] [Full Text] [Related]
4. The use of oral antifungal agents to treat onychomycosis. Gupta AK; Ryder JE Dermatol Clin; 2003 Jul; 21(3):469-79, vi. PubMed ID: 12956199 [TBL] [Abstract][Full Text] [Related]
5. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis. Chang CH; Young-Xu Y; Kurth T; Orav JE; Chan AK Am J Med; 2007 Sep; 120(9):791-8. PubMed ID: 17765049 [TBL] [Abstract][Full Text] [Related]
6. The treatment of dermatophytosis: safety considerations. Smith EB J Am Acad Dermatol; 2000 Nov; 43(5 Suppl):S113-9. PubMed ID: 11044286 [No Abstract] [Full Text] [Related]
8. [How I treat onychomycosis using pulsed therapy]. Piérard GE Rev Med Liege; 1997 Jun; 52(6):379-81. PubMed ID: 9289767 [No Abstract] [Full Text] [Related]
9. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis. Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131 [TBL] [Abstract][Full Text] [Related]
10. Oral treatment options for onychomycosis. Joseph WS J Am Podiatr Med Assoc; 1997 Nov; 87(11):520-31. PubMed ID: 9397657 [TBL] [Abstract][Full Text] [Related]
11. [Terbinafine (Lamisil)]. Breton MC Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634 [No Abstract] [Full Text] [Related]
15. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens. Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753 [TBL] [Abstract][Full Text] [Related]
16. Current trends in onychomycosis therapy: a literature review. Hecker D Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835 [TBL] [Abstract][Full Text] [Related]
17. Onychomycosis. Agents of choice. Hay RJ Dermatol Clin; 1993 Jan; 11(1):161-9. PubMed ID: 8382121 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of fluconazole for the treatment of onychomycosis. Brown SJ Ann Pharmacother; 2009 Oct; 43(10):1684-91. PubMed ID: 19776299 [TBL] [Abstract][Full Text] [Related]
19. Dermatophytosis: the management of fungal infections. Gupta AK; Ryder JE; Chow M; Cooper EA Skinmed; 2005; 4(5):305-10. PubMed ID: 16282753 [TBL] [Abstract][Full Text] [Related]
20. Update on the safety of itraconazole pulse therapy in onychomycosis and dermatomycoses. Gupta A; Lambert J; Revuz J; Shear N Eur J Dermatol; 2001; 11(1):6-10. PubMed ID: 11174129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]